Scholarlink

<p>Obesity, a growing global health challenge, requires effective treatment modalities, among which bariatric surgery is the gold standard for patients with Class III obesity (BMI ≥ 40&#xa0;kg/m² or ≥ 35&#xa0;kg/m² with comorbidities). While surgical outcomes are well established, the role of routine preoperative Esophagogastroduodenoscopy (EGD) remains debated. This study evaluates the role of EGD in preoperative planning among a Turkish cohort.&#xa0;</p><p>We conducted a retrospective cross-sectional analysis of 117 patients who underwent Laparoscopic Sleeve Gastrectomy (LSG) or Laparoscopic Roux-en-Y Gastric Bypass (LRYGB) between 2018 and 2021. Data on demographics, comorbidities, endoscopic and histopathologic findings, and surgical modifications were collected. Preoperative EGD revealed pathology in 86.3% of patients, including antral gastritis (64.1%), hiatal hernia (22.2%), and erosive esophagitis (18.8%). Chronic gastritis was confirmed histopathologically in 74.4%, and active Helicobacter pylori infection was identified in 15.4% of surgical specimens. Notably, EGD findings led to changes in surgical management in 18.8% of cases.</p><p>Our findings support the utility of routine EGD in bariatric surgery, emphasizing its role in identifying otherwise undetected pathologies that influence surgical decision-making. Further multicenter prospective studies are warranted.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Routine endoscopy prior to bariatric surgery: evidence-based necessity or institutional tradition?

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年10月21日

查看全文
  • Serhat Doğan,
  • Burhan Hakan Kanat

摘要

Obesity, a growing global health challenge, requires effective treatment modalities, among which bariatric surgery is the gold standard for patients with Class III obesity (BMI ≥ 40 kg/m² or ≥ 35 kg/m² with comorbidities). While surgical outcomes are well established, the role of routine preoperative Esophagogastroduodenoscopy (EGD) remains debated. This study evaluates the role of EGD in preoperative planning among a Turkish cohort. 

We conducted a retrospective cross-sectional analysis of 117 patients who underwent Laparoscopic Sleeve Gastrectomy (LSG) or Laparoscopic Roux-en-Y Gastric Bypass (LRYGB) between 2018 and 2021. Data on demographics, comorbidities, endoscopic and histopathologic findings, and surgical modifications were collected. Preoperative EGD revealed pathology in 86.3% of patients, including antral gastritis (64.1%), hiatal hernia (22.2%), and erosive esophagitis (18.8%). Chronic gastritis was confirmed histopathologically in 74.4%, and active Helicobacter pylori infection was identified in 15.4% of surgical specimens. Notably, EGD findings led to changes in surgical management in 18.8% of cases.

Our findings support the utility of routine EGD in bariatric surgery, emphasizing its role in identifying otherwise undetected pathologies that influence surgical decision-making. Further multicenter prospective studies are warranted.